Fig. 2: Kaplan–Meier plots of PFS per investigator (a) and BICR (b).

BF bireociclib plus fulvestrant; BICR blinded independent central review; CI confidence interval; F placebo plus fulvestrant; HR hazard ratio; PFS progression-free survival.
BF bireociclib plus fulvestrant; BICR blinded independent central review; CI confidence interval; F placebo plus fulvestrant; HR hazard ratio; PFS progression-free survival.